HomePress-release

Redding, California - March 14, 2024

VNA & PACS Market to be Worth $6.50 Billion by 2031

VNA & PACS Market by Procurement (PACS [Departmental {Radiology, Mammography, Dental} Enterprise] VNA [Enterprise, Multi-site] [CT, Angiography, MRI, Ultrasound]), Delivery (On Premise, Cloud, Hybrid), Vendor Type, End User - Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘VNA & PACS Market by Procurement (PACS [Departmental {Radiology, Mammography, Dental} Enterprise] VNA [Enterprise, Multi-site] [CT, Angiography, MRI, Ultrasound]), Delivery (On Premise, Cloud, Hybrid), Vendor Type, End User - Global Forecast to 2031.’

According to this latest publication from Meticulous Research^®, the VNA & PACS market is projected to reach $6.50 billion by 2031, at a CAGR of 7.2% during the forecast period. The growth of this market is driven by factors such as the increasing investments in medical imaging technologies, growing demand for imaging equipment, technological advancements in diagnostic imaging modalities, rising geriatric imaging volumes, growing big data presence in healthcare, and growing healthcare IT & EHR adoption. Moreover, the integration of PACS/VNA with EMR, penetration of Artificial intelligence (AI) in medical imaging, rising adoption of hybrid & cloud-based medical imaging solutions, and rapidly growing telehealth market are expected to offer significant market growth opportunities.

However, the longer product lifecycle of VNA and budgetary constraints restrain the market’s growth. Additionally, data migration and lack of interoperability pose challenges to the market’s growth.

Key Players

The key players operating in the VNA & PACS market are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China).

VNA & PACS Market: Future Outlook

The PACS market is segmented based on Procurement Model (Departmental PACS [Radiology PACS, Cardiology PACS, Mammography PACS {Traditional Mammography PACS, Vendor Neutral Mammography PACS}, Dental PACS, Other Departmental PACS], Enterprise PACS), Delivery Mode (On-Premise PACS, Web/Cloud-Based PACS), VNA market by Procurement Model (Enterprise VNA [Multi-Departmental VNA, Multi-Site VNA], Departmental VNA), Delivery Mode (On-Premise VNA, Hybrid VNA, Web/Cloud-Based VNA), VNA & PACS market as combined by Imaging Modality (Angiography, Computed Tomography (CT), Mammography, Magnetic Resonance Imaging (MRI), Ultrasound, Other Imaging Modalities), Vendor Type (Independent Software Vendors, PACS Vendors, Infrastructure Vendors), End User (Hospitals, Diagnostic Imaging Centers, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on procurement model, the VNA & PACS market is segmented into departmental PACS and enterprise PACS. In 2024, the departmental PACS segment is expected to account for the largest share of the PACS market. The large share of this segment is attributed to the increase in the use of imaging data in various departments such as radiology, cardiology, ophthalmology, oncology, endoscopy, dermatology, radiology, pathology, neurology, and dentistry. Also, the increase in adoption of imaging modalities further contributes to the growth of this segment. Furthermore, the radiology PACS segment is expected to account for the largest share of the departmental PACS market. The large share of this segment is attributed to the growing healthcare industry, growing radiology services in developing countries, increasing volumes of digital medical images, availability of PACS technology, favorable reimbursement for diagnostic imaging, and advancements in imaging technologies.

Based on delivery mode, the PACS market is segmented into on-premise PACS and web/cloud-based PACS. In 2024, the on-premise PACS segment is expected to account for the larger share of the PACS market. An on-premise PACS consists of a server installed locally inside a facility with software installed on the server and the facility’s computers. The images generated are viewed over the LAN and/or outside the network via a secure connection. Additionally, the benefits offered by the on-premise PACS, such as faster access to data and high control over their data security, are the factors contributing to the significant market share of this segment.

Based on procurement model, the VNA market is segmented into enterprise VNA and departmental VNA. In 2024, the enterprise VNA segment is expected to account for the larger share of the VNA market. The large market share of this segment can be attributed to the various benefits offered by the enterprise VNA, such as improved data exchange and interoperability, enhanced technology management, integration with EMRs, reduced storage and migration costs, and improved technology management.

Based on delivery mode, the VNA market is segmented into on-premise VNA, hybrid VNA, and web/cloud-based VNA. In 2024, the on-premise VNA segment is expected to account for the largest share of the VNA market. This segment's large market share can be attributed to the benefits offered by on-premise VNA, such as greater security, control over images, and lower latency than cloud storage.

Based on imaging modalities, the VNA & PACS market is segmented into angiography, computed tomography (CT), mammography, magnetic resonance imaging (MRI), ultrasound, and other imaging modalities. In 2024, the computed tomography (CT) segment is expected to account for the largest share of the VNA & PACS market. VNA and PACS platforms facilitate the integration of many imaging modalities, including CT, into a single system. The resulting interface enables healthcare facilities to speed up their imaging procedures, increase interaction, and make CT scans more accessible to clinicians and radiologists. In addition, it offers high security of data and improves patient care.

Based on vendor types, the VNA & PACS market is segmented into independent software vendors, PACS vendors, and infrastructure vendors. In 2024, the independent software vendors segment is expected to account for the largest share of the VNA & PACS market. As the adoption of electronic health records (EHR) and digital imaging expands, there is a growing need for advanced software solutions that can efficiently store, manage, and retrieve medical images. Independent software vendors capitalize on this demand by developing comprehensive and innovative VNA and PACS software solutions. Furthermore, the rising demand for VNA & PACS solutions in healthcare organizations contributes to the significant market share of this segment.

Based on end users, the VNA & PACS market is segmented into hospitals, diagnostic imaging centers, and other end users. In 2024, the hospitals segment is expected to account for the largest share of the VNA & PACS market. The large share of this segment is attributed to the growing number of hospital admissions, the rising number of hospitals in developing countries, and the adoption of VNAs in hospitals. Also, the growing demand for enterprise-wide image data management in hospitals further contributes to the growth of this segment.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.

In 2023, North America is expected to account for the largest share of the VNA & PACS market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the presence of major VNA & PACS companies, advanced healthcare & health IT infrastructure, increasing demand for standard-based medical image archiving & non-DICOM content management, technological advancements in diagnostic imaging modalities & image management solutions, rapid growth in geriatric imaging volumes, growing focus on value-based care, and growing big data presence in healthcare are some of the major factors driving the growth of this regional segment.

Download Sample Reportr Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=4440

Key questions answered in the report:

Which are the high-growth market segments in terms of procurement model, delivery mode, imaging modality, vendor type, end user, and region/country?
What was the historical market size for VNA & PACS across the globe?
What are the market forecasts and estimates for 2024–2031?
What are the major drivers, restraints, opportunities, and challenges in the global VNA & PACS market?
Who are the major players in the global VNA & PACS market?
What is the competitive landscape like, and who are the market leaders in the global VNA & PACS market?
What are the recent developments in the VNA & PACS market?
What strategies are adopted by the major players in the VNA & PACS market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - March 14, 2024

VNA & PACS Market to be Worth $6.50 Billion by 2031

VNA & PACS Market by Procurement (PACS [Departmental {Radiology, Mammography, Dental} Enterprise] VNA [Enterprise, Multi-site] [CT, Angiography, MRI, Ultrasound]), Delivery (On Premise, Cloud, Hybrid), Vendor Type, End User - Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies